BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/9/2022 12:48:14 PM | Browse: 990 | Download: 2362
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 75013
Country Australia
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Observational Study
Article Title To scope or not - the challenges of managing patients with positive fecal occult blood test after recent colonoscopy
Manuscript Source Unsolicited Manuscript
All Author List Nivedita Rattan, Laura Willmann, Diana Aston, Shani George, Milan Bassan, David Abi-Hanna, Sulakchanan Anandabaskaran, George Ermerak, Watson Ng and Jenn Hian Koo
ORCID
Author(s) ORCID Number
Nivedita Rattan http://orcid.org/0000-0002-8949-9607
Laura Willmann http://orcid.org/0000-0001-6852-6082
Diana Aston http://orcid.org/0000-0003-1226-2465
Shani George http://orcid.org/0000-0001-9410-1272
Milan Bassan http://orcid.org/0000-0002-5216-5961
David Abi-Hanna http://orcid.org/0000-0002-0530-2871
Sulakchanan Anandabaskaran http://orcid.org/0000-0002-3253-8062
George Ermerak http://orcid.org/0000-0002-5912-787X
Watson Ng http://orcid.org/0000-0001-5424-6266
Jenn Hian Koo http://orcid.org/0000-0003-2632-0830
Funding Agency and Grant Number
Corresponding Author Jenn Hian Koo, FRACP, MBBS, PhD, Doctor, Doctor, Gastroenterology and Liver Services, Liverpool Hospital, Elizabeth Street, Liverpool 2170, New South Wales, Australia. jenn.koo@health.nsw.gov.au
Key Words Colorectal cancer; Adenoma; Screening; Fecal occult blood test; Colonoscopy
Core Tip Currently, there is minimal consensus to inform clinicians of the appropriate approach to manage patients presenting with positive immunochemical fecal occult blood test (iFOBT) following a recent colonoscopy. This may lead to additional unnecessary, invasive procedure which confers procedure-related risks, as well as avoidable patient anxiety and a higher cost-burden on the healthcare system. Our study revealed that a previous colonoscopy, irrespective of its result, was associated with low prevalence of advanced neoplasia, and if performed within 4 years of a positive iFOBT result, was protective against colorectal cancer.
Publish Date 2022-09-09 12:48
Citation Rattan N, Willmann L, Aston D, George S, Bassan M, Abi-Hanna D, Anandabaskaran S, Ermerak G, Ng W, Koo JH. To scope or not - the challenges of managing patients with positive fecal occult blood test after recent colonoscopy. World J Gastrointest Oncol 2022; 14(9): 1798-1807
URL https://www.wjgnet.com/1948-5204/full/v14/i9/1798.htm
DOI https://dx.doi.org/10.4251/wjgo.v14.i9.1798
Full Article (PDF) WJGO-14-1798.pdf
Full Article (Word) WJGO-14-1798.docx